检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]山东省立医院化疗科,山东济南250021 [2]潍坊市人民医院保健科,山东潍坊261041
出 处:《山东大学学报(医学版)》2006年第9期914-917,共4页Journal of Shandong University:Health Sciences
摘 要:目的:检测胃癌组织中Her-2/neu,Syndecan-1表达情况,探讨二者在胃癌发生发展及侵袭、转移中的作用。方法:应用免疫组化SP法检测112例胃癌组织及40例正常胃粘膜中Her-2/neu,Syndecan-1表达。结果:①112例胃癌组织和40例正常胃粘膜中Her-2/neu阳性表达率分别为20.5%和5%,Syndecan-1阳性表达率分别为46.4%和100.0%。胃癌组织Her-2/neu阳性表达率显著高于正常胃粘膜阳性表达率(χ2=5.17,P<0.05),正常胃粘膜Syndecan-1阳性表达率显著高于胃癌组织(χ2=20.80,P<0.01);②胃癌组织Her-2/neu的表达与胃癌分化程度(χ2=4.82,P<0.05),TNM分期(χ2=5.37,P<0.05)、淋巴结转移多少(χ2=6.42,P<0.05)及浆膜浸润(χ2=7.30,P<0.01)均显著相关;③胃癌组织Syndecan-1的表达与胃癌分化程度、淋巴结转移呈负相关(χ2=11.83,P<0.01和χ2=13.74,P<0.01);④胃癌组织中Her-2/neu阳性表达与Syndecan-1的阴性表达显著相关(χ2=14.25,P<0.01)。结论:①Her-2/neu高表达显示胃癌恶性程度高、分期晚、预后不良;②Syndecan-1属保护性因素,在恶性程度高、分期晚的患者中表达降低;③Her-2/neu阳性表达的胃癌组织中Syndecan-1的表达降低。Objective: To study the effect of Her-2/neu and Syndecan-1 in gastric carcinoma. Methods: The expressions of Her-2/neu and Syndecan-1 were measured by using immunohistochemistry method in 112 patients with gastric cancer and 40 healthy controls. Results: ① Her-2/neu was expressed in 20.5 % of the gastric cancer tissue and 5.0% of the healthy gastric mucosa ( X^2 = 5.17, P 〈 0.05), and Syndecan-1 was expressed in 46.4% of the gastric cancer tissue and 100% of the healthy mucosa ( X^2 = 20.80, P 〈 0.01 ) ; ② the expression of Her-2/neu was significantly correlated with the differentiation, lymph node metastasis and clinical stage ( P 〈 0.05) and depth of invasion (P 〈0.01); ③ the expression of Syndecan-1 was significantly correlated with the differentiation and the lymph node metastasis (P 〈 0.01). Conclusion: ① The expression of Her-2/neu is significantly correlated with the clinicopathological factors ( P 〈 0.05) which suggests that Her-2/neu is a risk factor for gastric cancer; ② the expression of Syndecan- 1 is significantly correlated with the differentiation and the lymph node metastasis, which suggests that Syndecan-1 is a protective factor for gastric cancer; ③ the expression of Her-2/neu in gastric cancer tissue is significantly correlated with that of Syndecan-1.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229